University of Surrey

Test tubes in the lab Research in the ATI Dance Research

A phase I/II study of Enadenotucirev, an oncolytic Ad11/Ad3 chimeric group B adenovirus, administered intraperitoneally (IP): Dose finding and proof of concept in platinum-resistant epithelial ovarian cancer.

McNeish, IA, Michael, A, Twelves, C, Glasspool, R, Ajaz, MA, Morrison, R, Xeniou, O, Brown, R, Fisher, K and Blanc, C (2015) A phase I/II study of Enadenotucirev, an oncolytic Ad11/Ad3 chimeric group B adenovirus, administered intraperitoneally (IP): Dose finding and proof of concept in platinum-resistant epithelial ovarian cancer. In: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2015-05-29 - 2015-06-02, Chicago, IL.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Authors :
NameEmailORCID
McNeish, IAUNSPECIFIEDUNSPECIFIED
Michael, Aa.michael@surrey.ac.ukUNSPECIFIED
Twelves, CUNSPECIFIEDUNSPECIFIED
Glasspool, RUNSPECIFIEDUNSPECIFIED
Ajaz, MAUNSPECIFIEDUNSPECIFIED
Morrison, RUNSPECIFIEDUNSPECIFIED
Xeniou, OUNSPECIFIEDUNSPECIFIED
Brown, RUNSPECIFIEDUNSPECIFIED
Fisher, KUNSPECIFIEDUNSPECIFIED
Blanc, CUNSPECIFIEDUNSPECIFIED
Date : 20 May 2015
Contributors :
ContributionNameEmailORCID
publisherAMER SOC CLINICAL ONCOLOGY, UNSPECIFIEDUNSPECIFIED
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Oncology
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:36
Last Modified : 17 May 2017 14:51
URI: http://epubs.surrey.ac.uk/id/eprint/828469

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800